Top 10 Key Players in the Vietnam Dermatitis Market | Top Companies & Insights 2026

Vietnam Dermatitis Market Overview

According to 6Wresearch, the Vietnam Dermatitis market is projected to rise, due to the growing awareness levels and the occurrence of inflammatory skin disorders. Dermatitis is a condition that affects skin barrier function and immune response, and is being recognized for its impact on quality of life.

The market is fuelled by the need to develop effective treatments, along with an increasing focus on dermatological health, which is gaining momentum. Moreover, organizations are investing heavily in R&D to cater to the needs of individuals suffering from Atopic Dermatitis and Eczema.

Competitive Landscape

The competitive landscape in the Vietnam Dermatitis Industry is characterized by multinational pharmaceutical companies that use their superior R&D capabilities to bring innovations in the treatment of chronic skin disorders. The multinational pharmaceutical companies are currently focused on expanding their footprint by forging strategic partnerships and conducting clinical trials in the country.

Below is a list of leading players operating in the Vietnam Dermatitis Market:

1. Sanofi SA

Sanofi is a dominant force in immunology, providing advanced biologic treatments that target underlying type 2 inflammation pathways in dermatitis.

2. Pfizer Inc.

Pfizer maintains a strong presence, focusing on its inflammation and immunology portfolio, including JAK inhibitors for moderate-to-severe dermatitis.

3. Novartis International AG

Novartis contributes to the market through its expertise in specialty dermatology and its commitment to developing innovative therapies for chronic skin conditions.

4. AbbVie Inc.

AbbVie is a key player, particularly through its immunology division, focusing on advanced systemic treatments for patients with refractory dermatitis.

5. LEO Pharma

LEO Pharma is a significant provider of medical dermatology treatments, specializing in topical and systemic solutions for eczema and skin infections.

6. Imexpharm Pharmaceutical Joint Stock Company

A leading local manufacturer with EU-GMP certified facilities, providing high-quality generic topical steroids and anti-inflammatory solutions.

7. DHG Pharmaceutical Joint-Stock Company

DHG produces a wide range of supportive medications and dermatological creams used in managing the symptoms of various skin disorders.

8. Traphaco Joint Stock Company

Traphaco is highly regarded for its innovation in combining modern and traditional medicine for skin health and inflammatory relief.

9. Davipharm (Adamed Group)

Specializes in high-tech generic medicines and maintains EU-GMP standards to provide affordable, effective treatments for allergic and skin conditions.

10. Mekophar Chemical Pharmaceutical Joint Stock Company

A long-standing company specializing in both prescription and non-prescription topical drugs, ensuring the availability of essential skin care medicines.